PATENT CLAIM ANALYSIS

Application Number: 15903597
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "255040"]

Abstract:
The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.

Claim (Index 25):
A method of providing a faster onset of action for relief of allergic rhinitis in a pediatric human subject in need thereof, the method comprising nasally administering to a subject twice daily, one spray per nostril of a fixed-dose pharmaceutical composition comprising mometasone furoate and olopatadine hydrochloride, wherein (i) each spray comprises about 25 mcg of mometasone furoate and about 665 mcg olopatadine hydrochloride, and (ii) the administration provides relief from one or more symptoms of allergic rhinitis faster than nasal administration of 25 mcg mometasone furoate or 665 mcg olopatadine hydrochloride alone.

Metadata:
- Claim Count in Document: 60.0
- Percentile: 88.0
- Lexical Diversity: 1.31579
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15636120', '15842063', '14682001', '14506122', '15183534']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8787818356823771
- 35 USC 102 Novelty (BERT): 0.7187496835276003
- Combined Prediction Score: 0.8627786204668995
- Mean Citation Score: 768.203946
- Max Citation Score: 877.3085
- Similarity Product: 770.2016859974265

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test